Table 1. Clinical characteristics of BeS and CBD subjects.
| HS blood (n = 10) | BeS-NS blood (n = 10) | CBD blood (n = 10) | NDRI HS BAL (n = 6) | CBD BAL (n = 14) | BeS-NS BAL (n = 14) | BeS-S BAL (n = 10) | |
|---|---|---|---|---|---|---|---|
| Age (yr) | 67(55–73) | 64(50–73) | 64(52–75) | 52 (43–57) | 60 (49–73) | 63 (38–72) | 50(40–65) |
| Gender (M/F) | 8/2 | 9/1 | 9/1 | 4/2 | 12/2 | 10/4 | 8/2 |
| Race (W/AA/H) | 10/0/0 | 9/1/0 | 9/1/0 | 6/0/0 | 11/0/3 | 13/1/0 | 9/0/1 |
| Smoking status (CS/FS/NS) | 0/0/10 | 0/0/10 | 0/0/10 | 0/0/6 | 0/0/14 | 0/0/14 | 10/0/0 |
| BAL cells Lymphocytes (%) | NA | NA | NA | NA | 16 (4–38.5)* | 6.7 (1.5–16.5) | 3.95 (1–25.3) |
| BAL cells Total WBC count (millions) | NA | NA | NA | NA | 44(33–50.1) | 58.3 (27.5–66.7) | 100(21–365)* |
Data are expressed as median (range). W, white; AA, African American; H, Hispanic; CS, current smoker; FS, former smoker, NS, never smoker. *p<0.05